Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-03-19

Clinical Trial Update: Cardiovascular Effects of Selective I(f)-Channel Blockade [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update examining the cardiovascular effects of selective I(f)-channel blockade in Postural Orthostatic Tachycardia Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hannover Medical School | Conditions: Postural Orthostatic Tachycardia Syndrome | Phase 2 | Status: UNKNOWN